AVITA Medical, Inc. (ASX:AVH)
1.125
+0.005 (0.45%)
Feb 11, 2026, 12:29 PM AEST
AVITA Medical Revenue
AVITA Medical had revenue of $17.06M USD in the quarter ending September 30, 2025, a decrease of -12.71%. This brings the company's revenue in the last twelve months to $72.40M, up 20.59% year-over-year. In the year 2024, AVITA Medical had annual revenue of $64.25M with 28.14% growth.
Revenue (ttm)
$72.40M
Revenue Growth
+20.59%
P/S Ratio
1.60
Revenue / Employee
$278.47K
Employees
260
Market Cap
175.06M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 1.40M | 4.23% |
| Dec 31, 2021 | 33.03M | 3.79M | 12.98% |
| Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
AVITA Medical News
- 13 days ago - Avita Medical: Set Up For A Turnaround - Seeking Alpha
- 15 days ago - AVITA Medical (RCEL) Analyst Rating: Maintained 'Buy' with $10 PT | RCEL Stock News - GuruFocus
- 15 days ago - AVITA Medical (RCEL) Showcases Breakthrough Data at 2026 Burn Symposium - GuruFocus
- 26 days ago - AVITA Medical (RCEL): Analyst Lowers Price Target, Maintains Buy Rating | RCEL Stock News - GuruFocus
- 26 days ago - AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 27 days ago - AVITA Jumps On Preliminary FY25 Revenue Growth And Refinanced Debt Update - Nasdaq
- 4 weeks ago - AVITA Medical (RCEL) Secures $60M Credit Facility to Boost Growth - GuruFocus
- 4 weeks ago - Avita Medical (RCEL) Projects Strong Revenue Growth for FY26 - GuruFocus